| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.13B | -8.3% |
| Gross profit | ¥0.07B | — |
| Operating income | ¥-0.06B | — |
| Net income | ¥-0.06B | — |
| Gross margin | 52.4% | Net margin -45.7% |
| Revenue Q/Q | -70.0% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.06B | 47.6% |
| R&D | ¥0.04B | 32.4% |
| SG&A | ¥0.09B | 72.8% |
| Tax & other | ¥0.00B | 0.2% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
依米康 ・ 初灵信息 ・ 金信诺 ・ 卫宁健康 ・ 仟源医药 ・ 常山药业 ・ 星星科技 ・ 开山股份 ・ 精锻科技 ・ 新天科技 ・ 新莱应材 ・ 雅本化学
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies